NanoString Technologies, the Seattle-based maker of a genetic analysis instrument, said today it has hired two new vice presidents to fill out its commercial management team. Chris Grimley, the new vice president of marketing, previously worked at Agilent Technologies and Applied BioSystems. Katherine Webster, NanoString’s new vice president of worldwide sales, comes from Qiagen, and before that, 454 Life Sciences. NanoString has seen demand for its instrument increase in the past year, and it has staked out a new strategy to diversify beyond its base of academic research customers, and into a new market of cancer diagnostics.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
